SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-14-000458
Filing Date
2014-01-30
Accepted
2014-01-30 14:54:26
Documents
10
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2218042z10-q.htm 10-Q 393534
2 EX-31.1 a2218042zex-31_1.htm EX-31.1 14111
3 EX-32.1 a2218042zex-32_1.htm EX-32.1 7762
10 G604248.JPG g604248.jpg GRAPHIC 15105
  Complete submission text file 0001047469-14-000458.txt   3724576

Data Files

Seq Description Document Type Size
4 EX-101.INS nutr-20131231.xml EX-101.INS 306719
5 EX-101.SCH nutr-20131231.xsd EX-101.SCH 46319
6 EX-101.CAL nutr-20131231_cal.xml EX-101.CAL 61339
7 EX-101.DEF nutr-20131231_def.xml EX-101.DEF 170950
8 EX-101.LAB nutr-20131231_lab.xml EX-101.LAB 758239
9 EX-101.PRE nutr-20131231_pre.xml EX-101.PRE 406667
Mailing Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060
Business Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060 4356556000
NUTRACEUTICAL INTERNATIONAL CORP (Filer) CIK: 0001050007 (see all company filings)

IRS No.: 870515089 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-23731 | Film No.: 14560451
SIC: 2833 Medicinal Chemicals & Botanical Products